Grand Rounds and Doctor On Demand merge to revolutionize how millions of Americans receive healthcare in a first of its kind patient-centric virtual care organization.
A first of its kind integrated virtual care company is in the works through the collaboration of Grand Rounds, a leader in healthcare quality and navigation, and Doctor On Demand, the nation’s leading virtual care provider.
These two healthcare platforms will offer a full suite of digital and interactive solutions to help people address the $300 billion problem of uncoordinated care in the U.S., according to a release.
The new company will include a combination of Grand Rounds’ data-driven clinical navigation platform and patient advocacy tools with Doctor On Demand’s preeminent virtual care offering to provide an unparalleled member experience. It will accelerate the adoption of virtual care in key areas including primary care, specialty care, chronic condition management, and behavioral health.
Owen Tripp, CEO of Grand Rounds, will serve as the CEO of the expanded business. Both companies will continue to operate under their existing brands for the time being, the release said.
“No one has done this before, combining navigation and virtual care delivery," Tripp said. "We think it’s the future. People make unguided healthcare decisions every day, often with higher costs and worse outcomes. Now, with Doctor On Demand, we’ll offer them coordinated support on all fronts—physical, behavioral, financial, administrative—and we’ll do it for everything from acute issues to life-long health. This is truly complete care, and it’s what we all need.”
Hill Ferguson, CEO of Doctor On Demand, said the collaboration creates a next-generation virtual care company with a nationwide practice of diverse, dedicated providers and a multidisciplinary care team.
“By fully integrating medical and behavioral healthcare with clinical navigation, we’re impacting healthcare where it actually happens—between a patient and their provider—and ensuring that experience is seamless, personalized, and can follow the patient wherever they go,” Ferguson said.
The transaction is subject to regulatory approval and customary closing conditions and is expected to close in the first half of 2021. Terms of the transaction were not disclosed.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
A Renewed Commitment to HIV Vaccine Development Despite Advancements in Antiretrovirals | AIDS 2024
July 25th 2024The HIV vaccine field has recently faced setbacks with trials like PrepVacc, Mosaico and Imbokodo ending early due to lack of preventive efficacy. Although there have been challenges, scientists have made discoveries showing that the immune system can be prepared to fight HIV with special antibodies.
Read More
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
ViiV Healthcare Will Not Continue Trials of Subcutaneous Cabenuva | AIDS 2024
July 25th 2024A substudy of the FLAIR phase 3 trial found that participants favored intramuscular injection of Cabenuva over the subcutaneous version due to pain and the development of nodules and reddening of the skin.
Read More